Reversal of P-glycoprotein mediated vincristine resistance of L1210/VCR cells by analogues of pentoxifylline
- 1 February 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 21 (2-3) , 283-293
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistanceEuropean Journal of Pharmaceutical Sciences, 2001
- Multidrug resistance (MDR) in cancerEuropean Journal of Pharmaceutical Sciences, 2000
- Adenosine receptors and their ligandsNaunyn-Schmiedeberg's Archives of Pharmacology, 2000
- Alkylxanthines as research toolsJournal of the Autonomic Nervous System, 2000
- Potentiation of cADPR-Induced Ca2+-Release by Methylxanthine AnaloguesJournal of Medicinal Chemistry, 1999
- Structure-Activity Relationship of Xanthines and Skeletal Muscle Ryanodine Receptor/Ca2+ Release ChannelPharmacology, 1997
- Effect of TNFα production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:CToxicology, 1995
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs L1210 leukemia in miceJournal of Medicinal Chemistry, 1978
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976